1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Venlafaxine HCl | 盐酸万拉法新 | 99300-78-4 |
Vemurafenib (PLX4032) | 维罗非尼 | 918504-65-1 |
(4-(Benzyloxy)-3,5-difluorophenyl)boronic acid(contains varying amounts of Anhydride) | (4-(苄氧基)-3,5-二氟苯基)硼酸(含不等量的酸酐) | 156635-88-0 |
Verubulin | (4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺 | 827031-83-4 |
Vistusertib (AZD2014) | 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺 | 1009298-59-2 |
UNC1999 | UNC1999,EZH2甲基转移酶抑制剂 | 1431612-23-5 |
Uridine | 尿嘧啶核苷 | 58-96-8 |
Voriconazole (UK-109496) | 伏立康唑 | 137234-62-9 |
Volasertib (BI 6727) | N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 | 755038-65-4 |
UK 383367 | UK 383367,BMP-1(PCP)抑制剂 | 348622-88-8 |
VKGILS-NH2 TFA salt | VKGILS-NH2 TFA盐 | 942413-05-0 |
Varlitinib | 泛EGFR小分子抑制剂(VARLITINIB) | 845272-21-1 |
Uridine 5'-Diphospho-N-acetylglucosamine Disodium Salt | 尿苷-5′-二磷酸-N-乙酰基-葡糖胺钠盐 | 91183-98-1 |
2-Bromo-6-fluoro-4-methylaniline | 2-溴-6-氟-4-甲基苯胺 | 18349-09-2 |
5-Bromo-N,N,N-trimethylpentan-1-aminium bromide | 5-溴-N,N,N-三甲基戊烷-1-溴化铵 | 15008-33-0 |
Tylosin phosphate | 磷酸泰乐菌素 | 1405-53-4 |
Vatalanib (PTK787) 2HCl | 瓦他拉尼 | 212141-51-0 |
Tris(dimethylamido)antimony(III) | 三(二甲氨基)锑(III) | 7289-92-1 |
Trimethylolpropane propoxylate triacrylate | 丙氧基化三羟甲基丙烷三丙烯酸酯 | 53879-54-2 |
UNC 0224 | UNC 0224,G9a和GLP抑制剂 | 1197196-48-7 |
VU 0357121 | VU 0357121,mGlu5受体的正变构调节剂 | 433967-28-3 |
2-(3-But-3-ynyl-3H-diazirin-3-yl)-ethanol | 2-(3-丁-3-炔基-3H-双吖丙啶-3-基)-乙醇 | 1450754-41-2 |
tert-Butyl 2-aminobenzoate | 2-氨基苯甲酸叔丁酯 | 64113-91-3 |
Vardenafil | 瓦地那非 | 224785-90-4 |
3-Bromo-2-chloro-6-hydroxybenzaldehyde | 3-溴-2-氯-6-羟基苯甲醛 | 1427373-68-9 |
Victoria blue B | 维多利亚蓝B | 2580-56-5 |
Varespladib (LY315920) | 伐瑞拉迪 | 172732-68-2 |
1-(Bromomethyl)adamantane | 1-(溴甲基)金刚烷 | 14651-42-4 |
3-Bromo-4-methyl-4H-1,2,4-triazole | 3-溴-4-甲基-4H-1,2,4-三唑 | 16681-73-5 |
Ivacaftor (VX-770) | 依伐卡托 (VX-770) | 873054-44-5 |
6-(Bromomethyl)benzo[d]oxazole | 6-(溴甲基)苯并[d]噁唑 | 181040-42-6 |
Vecuronium Bromide | 维库溴铵 | 50700-72-6 |
Benzothiophene-3-sulfonyl chloride | 苯并噻吩-3-磺酰氯 | 18494-87-6 |
Vorinostat (SAHA) | N-羟基-N'-苯基辛二酰胺 | 149647-78-9 |
Vitamin D2 | 维生素D2 | 50-14-6 |
5-Bromo-[1,2,4]triazolo[1,5-a]pyridine | 5-溴[1,2,4]三唑并[1,5-A]吡啶 | 143329-58-2 |
1-(4-(Benzyloxy)-3-methoxyphenyl)ethanone | 4-苄氧基-3-甲氧基苯乙酮 | 1835-11-6 |
VK-II-36 | 化合物VK-II-43 | 955371-66-1 |
URB602 | 3-(环已氧羰基胺基)联苯 | 565460-15-3 |
URB597 | URB597,FAAH抑制剂 | 546141-08-6 |
U 19963 | 1,3-双(4-氟苯基)硫脲 | 404-52-4 |
Valdecoxib | 伐地考昔 | 181695-72-7 |
Tributylmethylammonium bis(trifluoromethylsulfonyl)imide | 三丁基甲基铵双(三氟甲基磺酰基)亚胺 | 405514-94-5 |
Vismodegib (GDC-0449) | 维莫德吉 | 879085-55-9 |
6-Bromo-7-fluoro-1H-indazole | 6-溴-7-氟-1H-吲唑 | 1427396-09-5 |
Titanium(II) hydride | 二氢化钛 | 7704-98-5 |
3-Boc-aminomethyl-pyrrolidine | 3-Boc-氨甲基吡咯烷 | 149366-79-0 |
Catharanthine | 长春质碱 | 2468-21-5 |
2-Bromo-4-iodo-1-methoxybenzene | 2-溴-4-碘-1-甲氧基苯 | 182056-39-9 |
Valsartan (CGP-48933) | 缬沙坦 | 137862-53-4 |
VU 0361737 | VU 0361737,mGlu4受体的正变构调节剂 | 1161205-04-4 |
Benzyl N-Boc-4-piperidinecarboxylate | N-Boc-4-哌啶甲酸苄酯 | 177990-33-9 |
Venetoclax (ABT-199) | ABT-199 | 1257044-40-8 |
UM729 | UM729 | 1448723-60-1 |
TEMPO | 2,2,6,6-四甲基哌啶氧化物 | 2564-83-2 |
Verteporfin (CL 318952) | 维替泊芬 | 129497-78-5 |
VU0810464 | VU0810464 | 2126040-21-7 |
Terpinolene | 萜品油烯 | 586-62-9 |
Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate | 三(2,2′-联吡啶)氯化钌(II) 六水合物 | 50525-27-4 |
Vildagliptin (LAF-237) | 维格列汀 | 274901-16-5 |
Vortioxetine (Lu AA21004) HBr | 氢溴酸沃替西汀 | 960203-27-4 |
Voxtalisib (XL765) Analogue | XL765 | 1349796-36-6 |
UNC1215 | UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 | 1415800-43-9 |
3-(3-(tert-Butoxy)-3-oxopropoxy)propanoic acid | 3-(3-(叔丁氧基)-3-氧代丙氧基)丙酸 | 2086689-08-7 |
Titanium(III,IV) oxide | 氧化钛(III,IV) | 12065-65-5 |
6-Bromo-2-methoxypyridin-3-ol | 6-溴-2-甲氧基吡啶-3-醇 | 1823333-27-2 |
Valrocemide | 丙戊塞胺 | 92262-58-3 |
4-Bromothiophene-3-carboxylic acid | 4-溴噻吩-3-羧酸 | 16694-17-0 |
Vinyl Decanoate (stabilized with MEHQ) | 癸酸乙烯酯(含稳定剂MEHQ) | 4704-31-8 |
3-(Trifluoromethyl)styrene | 3-(三氟甲基)苯乙烯 | 402-24-4 |
Tung oil | 桐油 | 8001-20-5 |
2-Bromo-5-(fluorosulfonyl)benzoic acid | 2-溴-5-(氟磺酰基)苯甲酸 | 1422570-52-2 |
Trimethylolpropane tris[poly(propylene glycol), amine terminated] ether | 三羟甲基丙烷三[聚(丙二醇),氨基封端]醚 | 39423-51-3 |
UVI 3003 | UVI 3003,RXR拮抗剂 | 847239-17-2 |
Vindoline | 文多灵 | 2182-14-1 |
Urapidil | 乌拉地尔 | 34661-75-1 |
Valaciclovir HCl | 盐酸万乃洛韦 | 124832-27-5 |
Terbium(III) oxide | 氧化铽 (III) | 12036-41-8 |
VX-745 | VX-745,p38 alpha MAPK抑制剂 | 209410-46-8 |
Uridine 5′-triphosphate trisodium salt hydrate | 尿苷-5′-三磷酸酯 三钠盐 水合物 | 19817-92-6 |
4-Bromo-2-(2,2,2-trifluoroethoxy)pyridine | 4-溴-2-(2,2,2-三氟乙氧基)吡啶 | 161952-62-1 |
2-(4-tert-Butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazle | 2-(4-叔丁苯基)-5-(4-联苯基)-1,3,4-恶二唑 | 15082-28-7 |
U-104 | U-104,碳酸酐酶(CA)IX和XII抑制剂 | 178606-66-1 |
VUF 10166 | VUF 10166,5-HT3拮抗剂 | 155584-74-0 |
2-Bromo-3,4-difluorobenzonitrile | 2-溴-3,4-二氟苄腈 | 1517611-20-9 |
5-Bromo-2-chloro-1,3-difluorobenzene | 3,5-二氟-4-氯溴苯 | 176673-72-6 |
USL311 | USL311 | 1373268-67-7 |
Vaseline | 白凡士林 | 8009-03-8 |
2-Bromo-4-fluoro-1-nitro-3-(trifluoromethyl)benzene | 2-溴-4-氟-1-硝基-3-(三氟甲基)苯 | 1805937-67-0 |
VU 0364770 | VU 0364770,mGlu4受体的正变构调节剂 | 61350-00-3 |
VU0134992 hydrochloride | VU0134992盐酸盐 | 1052515-91-9 |
VU 6005649 | VU 6005649,mGlu7和mGlu8受体的正变构调节剂 | 2137047-43-7 |
3-(Boc-amino)-3-methyl-1-butanol | (4-羟基-2-甲基丁-2-基)氨基甲酸叔丁酯 | 167216-22-0 |
VU 0364739 hydrochloride | VU 0364739 盐酸盐 | 1244640-48-9 |
(S,R,S)-AHPC-C4-NH2 dihydrochloride | (S,R,S)-AHPC-C4-NH2 二盐酸盐 | 2341796-78-7 |
UUN51204 | 7-Benzofurancarboxylic acid, 6-fluoro-, ethyl ester | 2114651-20-4 |
VUN65671 | VUN65671 | 2479465-67-1 |
2-Bromo-5-fluoro-4-nitropyridine | 2-溴-5-氟-4-硝基吡啶 | 1805578-52-2 |
VPC-80051 (Racemic) | VPC-80051 (消旋体) | 877969-69-2 |
4-Bromo-6-fluoro-2,3-dihydro-1H-inden-1-one | 4-溴-6-氟-2,3-二氢-1H-茚-1-酮 | 174603-56-6 |
联系方式